Journal of Enzyme Inhibition and Medicinal Chemistry · 2020 · 35 citations · 18 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryMolecular OncologyAntioxidant DefenseCancer MetabolismEnzyme InhibitionOncology PharmacologyReactive Oxygen SpeciesThioredoxin SystemAnticancer ActivityAnticancer ChemotherapyAnticancer Mechanism Of ActionAntiproliferative AgentsCarbonic Anhydrase FunctionCarbonic Anhydrase InhibitorsDual-target InhibitorsOxidative Stress In Cancer
The hypothesis that sulfocoumarin acting as inhibitors of human carbonic anhydrase (CA, EC 4.2.1.1) cancer-associated isoforms hCA IX and – hCA XII is being able to also inhibit thioredoxin reductase was verified and confirmed. The dual targeting of two cancer cell defence mechanisms, i.e. hypoxia and oxidative stress, may both contribute to the observed antiproliferative profile of these compounds against many cancer cell lines. This unprecedented dual anticancer mechanism may lead to a new approach for designing innovative therapeutic agents.
18